The effect of pre-treatment with Troxerutin on myocardial fibrosis in rats with doxorubicin-induced cardiotoxicity
Background. Doxorubicin (DOX) is a highly effective anthracycline drug widely used in cancer treatment. Myocardial fibrosis, a key pathological consequence of DOX-induced cardiotoxicity, impairs cardiac function and increases the risk of heart failure. Troxerutin (TXR), a natural bioflavonoid, has s...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Persa |
| I whakaputaina: |
Tabriz University of Medical Sciences
2025-08-01
|
| Rangatū: | مجله پزشکی دانشگاه علوم پزشکی تبریز |
| Ngā marau: | |
| Urunga tuihono: | https://mj.tbzmed.ac.ir/PDF/mj-47-287.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
